Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 29 · 3 feeds behind: Congress trades, 27 days, and 2 more · Every feed →

All 43,425Congress 1,562Executive branch 184Insiders 41,679
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

$50K+ · 43,425 trades

Trades
43,425
Buys 4,953 · Sells 38,455
People
7,541
Stocks
2,769
Disclosed value
$142B
range midpoints · Congress & executive
Filed late
3,112
  1. ▼ SELLJill DeSimone DirectorPRAX Praxis Precision Medicines, Inc.$264Kdisclosed Jun 26 · filed 2 days after the trade
  2. ▼ SELLKyle Clark DirectorBETA BETA Technologies, Inc.$248Kdisclosed Jun 26 · filed the same day
  3. ▼ SELLBiotechnology Value Fund II LP DirectorKYMR Kymera Therapeutics, Inc.$12.1Mdisclosed Jun 26 · filed the same day
  4. ▼ SELLBrandi Roberts Chief Financial OfficerDFTX Definium Therapeutics, Inc.$136Kdisclosed Jun 26 · filed 1 day after the trade
  5. ▼ SELLKimberly Cook-Nelson EVP & Chief Operating OfficerETR Entergy Corp$575Kdisclosed Jun 26 · filed 1 day after the trade
  6. ▼ SELLNathan Blecharczyk Chief Strategy OfficerABNB Airbnb, Inc.$3.6Mdisclosed Jun 26 · filed 2 days after the trade
  7. ▼ SELLIan Isaacs DirectorGLRE Greenlight Capital Re, Ltd.$64.2Kdisclosed Jun 26 · filed 1 day after the trade
  8. ▼ SELLJack Anders Chief Financial OfficerRVMD Revolution Medicines, Inc.$51.1Kdisclosed Jun 26 · filed 2 days after the trade
  9. ▼ SELLBrian D Connolly 10% ownerDBD Diebold NIXDORF, Inc$233Kdisclosed Jun 26 · filed 1 day after the trade
  10. ▼ SELLCheryl Alston DirectorGL Globe Life Inc.$463Kdisclosed Jun 26 · filed 1 day after the trade
  11. ▼ SELLBiotechnology Value Fund II LP DirectorKYMR Kymera Therapeutics, Inc.$89.2Mdisclosed Jun 26 · filed the same day
  12. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$372Kdisclosed Jun 26 · filed 1 day after the trade
  13. ▼ SELLBvf II GP LLC DirectorKYMR Kymera Therapeutics, Inc.$12.1Mdisclosed Jun 26 · filed the same day
  14. ▼ SELLJack Anders Chief Financial OfficerRVMD Revolution Medicines, Inc.$956Kdisclosed Jun 26 · filed 2 days after the trade
  15. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1Mdisclosed Jun 26 · filed 1 day after the trade
  16. ▼ SELLChristopher T Galla SVP, GC, and Corp. SecretaryGPC Genuine Parts Co$268Kdisclosed Jun 26 · filed the same day
  17. ▼ SELLJoseph S Konowiecki EVP, Corporate AffairsALHC Alignment Healthcare, Inc.$575Kdisclosed Jun 26 · filed the same day
  18. ▼ SELLMinchung Kgil Chief Financial OfficerFIGR Figure Technology Solutions, Inc.$88.6Kdisclosed Jun 26 · filed 2 days after the trade
  19. ▼ SELLBethany Mayer DirectorALAB Astera Labs, Inc.$65.7Kdisclosed Jun 26 · filed 2 days after the trade
  20. ▼ SELLCheryl Alston DirectorGL Globe Life Inc.$180Kdisclosed Jun 26 · filed 1 day after the trade
  21. ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$164Kdisclosed Jun 26 · filed 1 day after the trade
  22. ▼ SELLMillstreet Capital Management LLC 10% ownerDBD Diebold NIXDORF, Inc$19.2Mdisclosed Jun 26 · filed 2 days after the trade
  23. ▼ SELLJill DeSimone DirectorPRAX Praxis Precision Medicines, Inc.$544Kdisclosed Jun 26 · filed 2 days after the trade
  24. ▲ BUYBrian C Stephenson Chief Financial OfficerSNSE Faeth Therapeutics, Inc.$77.9Kdisclosed Jun 26 · filed 2 days after the trade
  25. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$268Kdisclosed Jun 26 · filed 1 day after the trade